Matt T Schulte is categorized under Noncommercial Biological Research Organization in Ellicott City, MD and active since 2004.
Matt T Schulte was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Noncommercial Biological Research Organization business, which does work in the B2B market, and is classified as a Noncommercial Biological Research Organization, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Matt Schulte at the company’s single location by writing to 4544 Hemlock Cone Way, Ellicott City, Maryland MD 21042 or by phoning (410) 461-3022. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Matt T Schulte |
Contact Person: | Matt Schulte |
Address: | 4544 Hemlock Cone Way, Ellicott City, Maryland 21042 |
Phone Number: | (410) 461-3022 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2004 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Noncommercial Biological Research Organization |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Matt T Schulte was started in 2004 to provide professional Noncommercial Biological Research Organization under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Matt Schulte for inquiries that concern Matt T Schulte by calling the company number (410) 461-3022, as your correspondence is most welcome. Additionally, the physical location of the single location of Matt T Schulte can be found at the coordinates 39.252615,-76.831143 as well as the street address 4544 Hemlock Cone Way in Ellicott City, Maryland 21042.
For its online presence, you may visit Matt T Schulte’s website at and engage with its social media outlets through on Twitter and on Facebook.